GoodRx director Bruehlman acquires 21,692 shares

Q: How many GDRX shares did director Ronald E. Bruehlman acquire?

Ronald E. Bruehlman acquired 21,692 Class A common shares on November 8, 2026, in a reported exercise/conversion of 21,692 deferred stock units. His directly held Class A shares following the transaction were 229,044.

A director's deferred stock unit award vested as to one-third of its underlying shares, with settlement tied to specified events.

Available on EDGAR 11/09/2026 - 04:21 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:20 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

GoodRx Holdings, Inc. director Ronald E. Bruehlman reported an exercise/conversion of 21,692 deferred stock units and acquisition of 21,692 Class A common shares on November 8, 2026. His directly held Class A shares following the transaction were 229,044. The award vested as to one-third of the shares underlying it. The deferred stock units will settle on the earliest of December 31, 2029, Separation from Service, a Change in Control, death, or Disability, as defined in the Deferred Compensation Plan for Directors.

Insider Trade Summary

21,692 shares exercised/converted

Exercise 2 txns

Insider Bruehlman Ronald E

Role Director

Type	Security	Shares	Price	Value
Exercise	Deferred Stock Unit ^{F2, F1}	21,692	$0.00	$0.00
Exercise	Class A Common Stock ^F1	21,692	--	--

Holdings After Transaction: Deferred Stock Unit — 21,692 units (Direct); Class A Common Stock — 229,044 shares (Direct)

Footnotes (2)

F1. The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
F2. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Key Figures

Deferred stock units exercised or converted: 21,692 units Class A common shares acquired: 21,692 shares Directly held Class A common shares following transaction: 229,044 shares +1 more

4 metrics

Deferred stock units exercised or converted 21,692 units November 8, 2026

Class A common shares acquired 21,692 shares November 8, 2026

Directly held Class A common shares following transaction 229,044 shares Following the November 8, 2026 transaction

Award vesting One-third of the shares underlying the award Vested November 8, 2026

Key Terms

Deferred Stock Unit, Separation from Service, Change in Control, contingent right

4 terms

Deferred Stock Unit technical

"The deferred stock unit award vested"

A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.

Separation from Service technical

"Separation from Service"

Change in Control technical

"a Change in Control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

contingent right technical

"represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GDRX shares did director Ronald E. Bruehlman acquire?

Ronald E. Bruehlman acquired 21,692 Class A common shares on November 8, 2026, in a reported exercise/conversion of 21,692 deferred stock units. His directly held Class A shares following the transaction were 229,044.

When will Ronald E. Bruehlman's GDRX deferred stock units settle?

The deferred stock units will settle on the earliest of December 31, 2029, Separation from Service, a Change in Control, death, or Disability, as defined in the Deferred Compensation Plan for Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bruehlman Ronald E

(Last)

(First)

(Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA

CALIFORNIA

90404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	11/08/2026		M		21,692	A	⁽¹⁾	229,044	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Unit	⁽²⁾	11/08/2026		M			21,692	⁽¹⁾	⁽¹⁾	Class A Common Stock	21,692	$0	21,692	D

Explanation of Responses:

1. The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

2. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Remarks:

	/s/ Gracye Cheng, Attorney-in-Fact for Ronald E Bruehlman	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR